Wave Life Sciences, Inc. (WVE)
Nasdaq · Pharmaceutical Preparations · Inc. DE
What they're doing
Not enough recent activity to summarise.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing material agreement
- Insider purchaseRA CAPITAL MANAGEMENT, L.P. (director) bought $6.3M of stock
- Insider purchaseRA CAPITAL MANAGEMENT, L.P. (director) bought $16.0M of stock
- Insider purchaseRA CAPITAL MANAGEMENT, L.P. (director) bought $30.0M of stock
- Insider purchaseRA CAPITAL MANAGEMENT, L.P. (director) bought $2.2M of stock
- Material 8-K filingFiled 8-K disclosing material agreement
- Large insider saleMoran Kyle (officer) sold $1.0M of stock
- Large insider saleMoran Kyle (officer) sold $1.0M of stock
- Large insider saleFrancis Chris (officer) sold $1.7M of stock
- Large insider saleFrancis Chris (officer) sold $1.7M of stock
- Large insider saleFrancis Chris (officer) sold $1.6M of stock
- Large insider saleFrancis Chris (officer) sold $1.6M of stock
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-08-12 | Rawcliffe Adrian | director | S | 12,700 | 5.29 | $67,183 |
| 2026-08-11 | Wagner Heidi L | director | M | 7,000 | 5.97 | $41,790 |
| 2026-08-11 | Wagner Heidi L | director | S | 7,000 | 6.01 | $42,070 |
| 2026-08-11 | TAKANASHI KEN | director | S | 3,864 | 6.01 | $23,223 |
| 2026-08-11 | Tan Aik Na | director | S | 432 | 6.01 | $2,596 |
| 2026-03-30 | RA CAPITAL MANAGEMENT, L.P. | director | P | 971,091 | 6.5 | $6,312,092 |
| 2026-03-30 | RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Kolchinsky Peter; Shah Rajeev M. | director | P | 971,091 | 6.5 | $6,312,092 |
| 2026-03-27 | RA CAPITAL MANAGEMENT, L.P. | director | P | 2,495,623 | 6.43 | $16,046,856 |
| 2026-03-27 | RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Kolchinsky Peter; Shah Rajeev M. | director | P | 2,495,623 | 6.43 | $16,046,856 |
| 2026-03-26 | RA CAPITAL MANAGEMENT, L.P. | director | P | 351,224 | 6.38 | $2,240,809 |
| 2026-03-26 | RA CAPITAL MANAGEMENT, L.P. | director | P | 4,954,558 | 6.06 | $30,024,621 |
| 2026-03-26 | RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Kolchinsky Peter; Shah Rajeev M. | director | P | 4,954,558 | 6.06 | $30,024,621 |
| 2026-03-26 | RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Kolchinsky Peter; Shah Rajeev M. | director | P | 351,224 | 6.38 | $2,240,809 |
| 2026-03-23 | TAKANASHI KEN | director | C | 3,901,348 | 0 | $0 |
| 2026-03-23 | TAKANASHI KEN | director | C | 3,901,348 | 0 | $0 |
| 2026-02-26 | Francis Chris | officer | M | 17,900 | 3.87 | $69,273 |
| 2026-02-26 | Francis Chris | officer | S | 17,900 | 15.09 | $270,111 |
| 2026-02-26 | Francis Chris | officer | M | 15,294 | 4.75 | $72,647 |
| 2026-02-26 | Francis Chris | officer | S | 15,294 | 15 | $229,410 |
| 2026-02-26 | Francis Chris | officer | M | 17,900 | 3.87 | $69,273 |
| 2026-02-26 | Francis Chris | officer | S | 17,900 | 15.09 | $270,183 |
| 2026-02-26 | Francis Chris | officer | M | 15,294 | 4.75 | $72,647 |
| 2026-02-26 | Francis Chris | officer | S | 15,294 | 15 | $229,410 |
| 2026-02-09 | Moran Kyle | officer | S | 3,588 | 13.45 | $48,259 |
| 2026-02-09 | BOLNO PAUL | director | S | 10,480 | 13.45 | $140,956 |
| 2026-02-09 | Francis Chris | officer | S | 1,883 | 13.45 | $25,326 |
| 2026-02-09 | Vargeese Chandra | officer | S | 3,228 | 13.45 | $43,417 |
| 2026-02-09 | Moran Kyle | officer | S | 3,588 | 13.45 | $48,259 |
| 2026-02-09 | BOLNO PAUL | director | S | 10,480 | 13.45 | $140,956 |
| 2026-02-09 | Francis Chris | officer | S | 1,883 | 13.45 | $25,326 |
| 2026-02-09 | Vargeese Chandra | officer | S | 3,228 | 13.45 | $43,417 |
| 2026-02-05 | Moran Kyle | officer | A | 45,625 | 0 | $0 |
| 2026-02-05 | BOLNO PAUL | director | A | 165,000 | 0 | $0 |
| 2026-02-05 | Francis Chris | officer | A | 38,750 | 0 | $0 |
| 2026-02-05 | Vargeese Chandra | officer | A | 45,625 | 0 | $0 |
| 2026-02-05 | Moran Kyle | officer | A | 45,625 | 0 | $0 |
| 2026-02-05 | BOLNO PAUL | director | A | 165,000 | 0 | $0 |
| 2026-02-05 | Francis Chris | officer | A | 38,750 | 0 | $0 |
| 2026-02-05 | Vargeese Chandra | officer | A | 45,625 | 0 | $0 |
| 2026-01-02 | Francis Chris | officer | S | 1,295 | 16.7 | $21,627 |
| 2026-01-02 | Francis Chris | officer | M | 9,375 | 3.14 | $29,438 |
| 2026-01-02 | Francis Chris | officer | S | 8,080 | 15.92 | $128,634 |
| 2026-01-02 | Francis Chris | officer | M | 9,375 | 3.14 | $29,438 |
| 2026-01-02 | Francis Chris | officer | S | 8,080 | 15.92 | $128,634 |
| 2026-01-02 | Francis Chris | officer | S | 1,295 | 16.7 | $21,627 |
| 2025-12-11 | GSK plc | ten percent owner | P | 1,470,000 | 19 | $27,930,000 |
| 2025-12-09 | Moran Kyle | officer | S | 50,000 | 20.03 | $1,001,500 |
| 2025-12-09 | Moran Kyle | officer | M | 50,000 | 10.48 | $524,000 |
| 2025-12-09 | Moran Kyle | officer | S | 36 | 20.25 | $729 |
| 2025-12-09 | Moran Kyle | officer | M | 36,000 | 8.17 | $294,120 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.
Recent filings
- 2026-08-14 EFFECT
- 2026-08-13 4
- 2026-08-13 4
- 2026-08-13 4
- 2026-08-13 4
- 2026-08-12 144
- 2026-08-11 SCHEDULE 13D/A
- 2026-08-11 144
- 2026-08-10 15-12G
- 2026-08-10 POS AM
- 2026-08-10 POSASR
- 2026-08-10 S-8 POS
- 2026-08-10 S-8 POS
- 2026-08-10 S-8 POS
- 2026-08-10 S-8 POS
- 2026-08-10 S-8 POS
- 2026-08-10 S-8 POS
- 2026-08-10 S-8 POS
- 2026-08-10 S-8 POS
- 2026-08-10 S-8 POS